Anaesthetic considerations in the management of heteropagus twins.
D000759:Adjuvants, Anesthesia / Q000627:therapeutic use; D018685:Anesthetics, Inhalation / Q000627:therapeutic use; D001285:Atropine / Q000627:therapeutic use*; D005260:Female; D006221:Halothane / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007442:Intubation, Intratracheal; D003473:Neuromuscular Nondepolarizing Agents / Q000627:therapeutic use; D009609:Nitrous Oxide / Q000627:therapeutic use*; D010100:Oxygen / Q000627:therapeutic use; D014428:Twins, Conjoined / Q000601:surgery*; D014673:Vecuronium Bromide / Q000627:therapeutic use*
D000759:Adjuvants, Anesthesia; D018685:Anesthetics, Inhalation; D003473:Neuromuscular Nondepolarizing Agents; D001285:Atropine; D014673:Vecuronium Bromide; D009609:Nitrous Oxide; D010100:Oxygen; D006221:Halothane